Filter

Refine by date

—

Refine by collections

  • Thyroid autoimmunity (1)
  • Print
  • Save

Search Results

You are looking at 1 - 1 of 1 items for :

  • papillary thyroid carcinoma x
  • Thyroid autoimmunity x
Clear All
Liyuan Liu Department of Endocrinology, Peking University First Hospital, Beijing, People’s Republic of China

Search for other papers by Liyuan Liu in
Google Scholar
PubMed Close
,
Yang Yu Department of Endocrinology, Peking University First Hospital, Beijing, People’s Republic of China

Search for other papers by Yang Yu in
Google Scholar
PubMed Close
,
Lei Chen Department of Ultrasound, Peking University First Hospital, Beijing, People’s Republic of China

Search for other papers by Lei Chen in
Google Scholar
PubMed Close
,
Yang Zhang Department of Endocrinology, Peking University First Hospital, Beijing, People’s Republic of China

Search for other papers by Yang Zhang in
Google Scholar
PubMed Close
,
Guizhi Lu Department of Endocrinology, Peking University First Hospital, Beijing, People’s Republic of China

Search for other papers by Guizhi Lu in
Google Scholar
PubMed Close
,
Ying Gao Department of Endocrinology, Peking University First Hospital, Beijing, People’s Republic of China

Search for other papers by Ying Gao in
Google Scholar
PubMed Close
, and
Junqing Zhang Department of Endocrinology, Peking University First Hospital, Beijing, People’s Republic of China

Search for other papers by Junqing Zhang in
Google Scholar
PubMed Close

to papillary thyroid carcinoma and may have worse clinical outcomes, including a larger tumour diameter and a higher percentage of lymph node metastasis ( 11 ). PTL accounts for 1–5% of all malignancies of the thyroid gland ( 7 ), and it is reported

Article Type:
Research Article
Collections:
Thyroid autoimmunity
DOI:
https://doi.org/10.1530/ETJ-21-0144
Volume/Issue:
Volume 11: Issue 3
Open access